high
mutat
rate
human
immunodefici
viru
type
viru
major
problem
sinc
evad
function
antibodi
chemic
inhibitor
demonstr
viral
detect
strategi
base
synthet
biolog
principl
detect
specif
viral
function
rather
particular
viral
protein
resist
caus
mutat
circumv
sinc
mutat
caus
loss
function
also
incapacit
viru
mani
pathogen
encod
proteas
essenti
replic
defin
substrat
specif
genet
encod
sensor
compos
fuse
membran
anchor
viral
proteas
target
site
orthogon
transcript
activ
engin
human
cell
line
proteas
releas
transcript
activ
membran
therebi
induc
transcript
select
gene
devic
still
strongli
activ
clinic
relev
proteas
mutant
resist
proteas
inhibitor
futur
similar
principl
could
appli
detect
also
pathogen
function
v
iral
diseas
repres
signific
challeng
medic
therapi
human
immunodefici
viru
type
one
difficult
virus
treat
hijack
cell
immun
system
use
viral
glycoprotein
bind
cellular
receptor
revers
transcriptas
transcrib
rna
dna
integras
integr
viral
genom
host
viral
proteas
cleav
viral
polyprotein
function
protein
viral
protein
still
investig
target
therapeut
inhibitor
interfer
viral
lifecycl
main
reason
difficulti
develop
effect
drug
lack
proofread
revers
transcriptas
consequ
mutat
occur
high
frequenc
therebi
modifi
sequenc
protein
resist
evolv
quickli
render
mani
chemic
inhibitor
antibodi
useless
effect
current
treatment
base
highli
activ
antiretrovir
therapi
employ
cocktail
sever
antiretrovir
drug
differ
target
base
differ
inhibit
mechan
therebi
decreas
probabl
simultan
mutat
escap
viral
protein
translat
gagpolpolyprotein
cleav
viral
proteas
polypeptid
chain
without
proteolyt
cleavag
viru
remain
noninfecti
dimer
aspart
viral
proteas
cleav
polyprotein
specif
viru
proteas
human
cell
supplement
function
random
mutat
proteas
abolish
pharmacolog
hiv
abil
replic
infect
addit
cell
proteas
one
first
target
therapi
proteas
inhibitor
still
use
treatment
howev
mutat
occur
within
proteas
may
retain
suffici
fraction
proteolyt
activ
support
viral
surviv
render
proteas
resist
inhibitor
rapid
mutat
rate
viru
result
larg
number
variant
even
within
individu
patient
select
pressur
antivir
therapi
lead
prolifer
drugresist
proteas
strain
mutant
consid
key
signatur
residu
mutat
proteas
develop
resist
saquinavir
saq
therapi
usual
cooccur
resist
mutat
mutat
posit
contribut
resist
viru
approv
proteas
inhibitor
mutant
one
first
drugresist
mutat
occur
proteas
patient
receiv
antivir
therapi
studi
consid
possibl
employ
synthet
biolog
principl
engin
cellular
devic
detect
infect
trigger
product
report
antivir
protein
reason
effect
biolog
antivir
devic
base
essenti
viral
function
rather
specif
protein
defin
sequenc
tertiari
structur
target
chemic
inhibitor
antibodi
reli
viral
function
viral
detect
less
sensit
mutat
one
possibl
use
devic
could
product
effector
alert
human
immun
system
presenc
viru
eg
product
interferon
ifn
chemokin
viral
activ
detect
devic
abl
transduc
signal
activ
select
effector
signal
devic
produc
robust
specif
signal
principl
behind
genet
encod
devic
detect
viral
proteas
activ
base
proteolyt
cleavag
peptid
linker
link
orthogon
transcript
activ
membran
anchor
viral
presenc
specif
viral
proteas
activ
sens
irrevers
proteolyt
step
caus
releas
transcript
activ
membran
activ
select
transcript
respons
activ
therefor
exist
two
state
inact
state
transcript
activ
locat
membran
bind
respect
oper
site
activ
state
transloc
nucleu
bind
activ
select
effector
gene
eg
report
human
engin
hybrid
transcript
factor
compos
dnabind
domain
activ
domain
link
proteas
cleavag
site
cellular
membran
transmembran
ectodomain
fa
receptor
figur
yeast
regulatori
protein
compris
dnabind
domain
linker
coiledcoil
dimer
domain
use
previous
orthogon
transcript
factor
mammalian
cell
domain
herp
simplex
viru
protein
recruit
hostencod
element
transcript
machineri
upstream
promot
select
peptid
linker
compris
proteas
cleavag
site
amino
acid
sequenc
also
call
peptid
use
synthet
hiv
proteas
substrat
effici
anchor
membran
select
nonfunct
transmembran
ectodomain
fa
typei
transmembran
receptor
found
surfac
immun
cell
thelper
cell
monocyt
macrophag
dendrit
cell
activ
devic
viral
proteas
observ
fluoresc
confoc
microscopi
use
fluoresc
protein
cyan
floresc
protein
cfp
mcherri
link
cleavabl
linker
peptid
proteas
cleavag
site
hivp
cytosol
side
transmembran
domain
human
embryon
kidney
hek
cell
transfect
plasmid
code
fusion
protein
ha
fa
ha
cotransfect
replicationincompet
pseudovir
genom
plasmid
therebi
encod
function
viral
proteas
absenc
genom
fluoresc
clearli
local
plasma
membran
figur
c
cell
cotransfect
genom
fluoresc
cfp
releas
membran
cytosol
figur
mcherri
compris
two
copi
larg
tantigen
nuclear
local
sequenc
nl
transloc
nucleu
figur
express
transmembran
protein
ha
fa
ha
surfac
cell
membran
also
confirm
stain
cell
antiha
antibodi
hatag
posit
extracellular
side
receptor
support
inform
figur
incorpor
transmembran
receptor
membran
demonstr
appropri
protein
fold
local
suggest
sensor
could
function
demonstr
sens
transcript
activ
devic
use
luciferas
report
assay
measur
express
luciferas
gene
induc
transcript
activ
transcript
activ
trigger
cleavag
linker
transmembran
receptor
proteas
releas
nucleu
activ
transcript
luciferas
control
oper
luciferas
activ
observ
cell
cotransfect
genom
plasmid
ha
support
inform
figur
fa
ha
support
inform
figur
synthet
proteas
inhibitor
inhibit
activ
presenc
saq
ritonavir
rtv
activ
report
reduc
ha
support
inform
figur
fa
ha
support
inform
figur
salient
featur
devic
less
sensit
mutat
caus
resist
proteas
inhibitor
viral
genom
encod
drugresist
proteas
mutant
exhibit
slightli
reduc
proteolyt
activ
comparison
wild
type
devic
construct
ha
fa
ha
support
inform
figur
probabl
impair
specif
activ
mutat
proteas
howev
proteolyt
effici
still
suffici
process
viral
polyprotein
viral
replic
clinic
observ
proteas
mutant
significantli
less
sensit
therapeut
proteas
inhibitor
cocktail
atazanavir
saq
rtv
wildtyp
proteas
figur
howev
devic
abl
robustli
sens
activ
proteas
mutant
trigger
gene
transcript
regardless
presenc
saq
cocktail
saq
rtv
shown
figur
ha
devic
obtain
similar
result
fa
ha
data
shown
find
demonstr
synthet
genet
devic
still
activ
proteas
mutat
resist
clinic
use
inhibitor
also
demonstr
activ
devic
nontox
proteas
precursor
fuse
green
fluoresc
protein
gfp
activ
devic
cell
significantli
lower
amount
gfppr
comparison
requir
support
inform
figur
proteas
mutant
gfppr
also
sens
devic
found
mutant
gfppr
almost
complet
resist
saq
use
western
blot
demonstr
express
level
precursor
protein
support
inform
figur
demonstr
devic
could
drive
express
differ
select
effector
gene
select
gene
human
member
type
ifn
famili
ifn
usual
secret
consequ
elev
level
dsrna
cell
use
antivir
therapi
found
express
level
produc
signal
depend
amount
transfect
proteas
figur
work
present
orthogon
cellular
signal
devic
activ
specif
proteas
use
proteas
trigger
select
activ
previous
report
trigger
cellular
genet
respons
program
addit
eukaryot
signal
pathway
previous
rewir
use
synthet
biolog
daring
et
al
recent
report
synthet
devic
mammalian
cell
sens
extracellular
ligand
ligand
bindinginduc
dimer
releas
orthogon
transcript
factor
independ
nativ
cellular
compon
engin
sens
devic
may
also
serv
tool
address
difficult
problem
host
defens
rapidli
mutat
virus
virus
avoid
immun
surveil
detect
specif
viral
function
coupl
synthet
signal
pathway
could
util
trigger
almost
select
transcript
respons
antivir
defens
use
devic
report
gene
replac
one
sever
effector
gene
demonstr
system
abl
trigger
product
human
serv
alarm
signal
neighbor
cell
defend
viral
infect
amount
produc
reach
ngml
sever
order
magnitud
higher
system
ifn
concentr
antivir
therapi
eg
mgday
everi
day
treatment
hepat
c
viru
hcv
one
potenti
applic
synthet
devic
could
detect
assay
screen
librari
drugresist
proteas
mutant
inhibitor
mammalian
cultur
cell
use
differ
report
includ
cell
toxic
protein
select
marker
advantag
use
cell
assay
proteas
activ
alreadi
report
author
use
differ
proteas
precursor
gfppr
probe
protein
forster
reson
energi
transferbas
proteasesensit
sensor
experiment
implement
signal
devic
found
also
faster
tworound
phenotyp
assay
test
isol
primari
purpos
describ
devic
target
essenti
viral
function
regardless
specif
sequenc
spatial
structur
particular
viral
compon
approach
import
advantag
comparison
detect
therapi
target
specif
viral
protein
antibodi
chemic
inhibitor
specif
interf
rna
molecul
effici
robust
depend
select
invari
segment
independ
viral
mutat
reli
statist
advantag
base
target
multipl
viral
protein
describ
principl
highli
specif
could
tailor
specif
proteas
replac
design
dnabind
domain
eg
tal
activ
could
also
rewir
signal
regul
product
select
endogen
gene
principl
functionbas
mutationindepend
signal
system
could
also
appli
detect
pathogen
particularli
virus
eg
sever
acut
respiratori
syndrom
sar
west
nile
viru
hand
foot
mouth
diseas
etc
mani
viral
proteas
welldefin
substrat
specif
could
implement
straightforward
manner
design
linker
peptid
exampl
hcv
proteas
serin
proteas
essenti
viral
replic
respons
proteolyt
cleavag
hcv
polyprotein
precursor
cleav
specif
amino
acid
sequenc
core
sequenc
cleavag
site
sarscoronaviru
cystein
proteas
respons
matur
function
viral
protein
also
highli
conserv
murray
valley
enceph
west
nile
viru
proteas
also
unusu
sequenc
recognit
specif
found
mammalian
proteas
final
functionbas
principl
could
use
detect
specif
viral
function
revers
transcript
integr
